...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2.
【24h】

Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2.

机译:血清淀粉样蛋白A通过Toll样受体2诱导G-CSF表达和中性粒细胞增多。

获取原文
获取原文并翻译 | 示例

摘要

The acute-phase protein serum amyloid A (SAA) is commonly considered a marker for inflammatory diseases; however, its precise role in inflammation and infection, which often result in neutrophilia, remains ambiguous. In this study, we demonstrate that SAA is a potent endogenous stimulator of granulocyte colony-stimulated factor (G-CSF), a principal cytokine-regulating granulocytosis. This effect of SAA is dependent on Toll-like receptor 2 (TLR2). Our data demonstrate that, in mouse macrophages, both G-CSF mRNA and protein were significantly increased after SAA stimulation. The induction of G-CSF was blocked by an anti-TLR2 antibody and markedly decreased in the TLR2-deficient macrophages. SAA stimulation results in the activation of nuclear factor-kappaB and binding activity to the CK-1 element of the G-CSF promoter region. In vitro reconstitution experiments also support that TLR2 mediates SAA-induced G-CSF expression. In addition, SAA-induced secretion of G-CSF was sensitive to heat and proteinase K treatment, yet insensitive to polymyxin B treatment, indicating that the induction is a direct effect of SAA. Finally, our in vivo studies confirmed that SAA treatment results in a significant increase in plasma G-CSF and neutrophilia, whereas these responses are ablated in G-CSF- or TLR2-deficient mice.
机译:急性期蛋白血清淀粉样蛋白A(SAA)通常被认为是炎性疾病的标志物。然而,它在炎症和感染(通常导致中性粒细胞增多)中的确切作用仍然不清楚。在这项研究中,我们证明了SAA是粒细胞集落刺激因子(G-CSF)(一种主要的细胞因子调节粒细胞增多)的有效内源性刺激剂。 SAA的这种作用取决于Toll样受体2(TLR2)。我们的数据表明,在小鼠巨噬细胞中,SAA刺激后G-CSF mRNA和蛋白质均显着增加。 G-CSF的诱导被抗TLR2抗体阻断,并在缺乏TLR2的巨噬细胞中明显降低。 SAA刺激导致核因子-κB的活化和与G-CSF启动子区域CK-1元件的结合活性。体外重建实验也支持TLR2介导SAA诱导的G-CSF表达。此外,SAA诱导的G-CSF分泌对热和蛋白酶K处理敏感,但对多粘菌素B处理不敏感,表明该诱导是SAA的直接作用。最后,我们的体内研究证实,SAA治疗可导致血浆G-CSF和中性粒细胞显着增加,而这些反应在G-CSF或TLR2缺陷型小鼠中被消除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号